Trials / Conditions / Recurrent Glioblastoma Multiforme (GBM)
Recurrent Glioblastoma Multiforme (GBM)
6 registered clinical trials studyying Recurrent Glioblastoma Multiforme (GBM) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurre NCT07501559 | Jecho Biopharmaceuticals Co., Ltd. | Phase 1 / Phase 2 |
| Enrolling By Invitation | The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM NCT06616727 | Shanghai Simnova Biotechnology Co.,Ltd. | Phase 1 |
| Completed | A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Gliobl NCT07497373 | Jecho Biopharmaceuticals Co., Ltd. | Phase 1 |
| Terminated | Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma NCT04782609 | Samus Therapeutics, Inc. | Phase 1 |
| Unknown | A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurre NCT05053880 | Accendatech USA Inc. | Phase 1 / Phase 2 |
| Terminated | Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multifo NCT00290771 | Novartis | Phase 2 |